These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19008591)

  • 1. Multiple myeloma presenting with coexisting severe marrow hypoplasia.
    Medhi K; Kalita D; Chopra A; Anand M; Raina V; Kumar R
    Indian J Pathol Microbiol; 2008; 51(4):543-5. PubMed ID: 19008591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry.
    Matsue K; Matsue Y; Kumata K; Usui Y; Suehara Y; Fukumoto K; Fujisawa M; Narita K; Takeuchi M
    Hematol Oncol; 2017 Sep; 35(3):323-328. PubMed ID: 27140172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent localized bone marrow aplasia after radiotherapy with preserved peripheral counts: a study of 8 cases.
    Harrington AM; Currey A; Olteanu H; Kroft SH
    Ann Diagn Pathol; 2010 Jun; 14(3):168-72. PubMed ID: 20471561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concomitant myeloid sarcoma and plasma cell myeloma--case report of a hitherto undescribed association of two neoplasms].
    Nowakowska-Kopera A; Wójcik M; Rudzki Z; Gałazka K; Skotnicki AB
    Pol Merkur Lekarski; 2007 Aug; 23(134):120-3. PubMed ID: 18044342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the kinetics of the bone marrow tumor load in the course of sequential high-dose therapy assessed by quantitative PCR as a predictive parameter in patients with multiple myeloma.
    Cremer FW; Ehrbrecht E; Kiel K; Benner A; Hegenbart U; Ho AD; Goldschmidt H; Moos M
    Bone Marrow Transplant; 2000 Oct; 26(8):851-8. PubMed ID: 11081384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.
    Ailawadhi S; Abdelhalim AN; Derby L; Mashtare TL; Miller KC; Wilding GE; Alberico RA; Gottlieb R; Klippenstein DL; Lee K; Chanan-Khan AA
    Cancer; 2010 Jan; 116(1):84-92. PubMed ID: 19862816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent diagnoses of Hodgkin lymphoma and biclonal myeloma in the bone marrow.
    Huppmann AR; Liu ML; Nava VE
    Ann Diagn Pathol; 2010 Aug; 14(4):268-72. PubMed ID: 20637433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of bone marrow biopsy and smear efficacy in patients with multiple myeloma].
    Su JY; Tao Y; Liu YZ; Zhou LY; Yang LP; Liu H; Chang CK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1389-91. PubMed ID: 23257439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic importance and pitfalls of evaluating bone marrow smear preparation in multiple myeloma].
    Scudla V; Adam Z
    Vnitr Lek; 2006 Nov; 52 Suppl 2():55-65. PubMed ID: 18175430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances of bone marrow biopsy pathology in diagnosing lymphoma bone marrow involvement].
    Liu EB; Chen HS
    Ai Zheng; 2005 Nov; 24(11):1416-20. PubMed ID: 16552975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual cases in multiple myeloma and a dramatic response in metastatic lung cancer: Case 2. Plasma cell myeloma coexisting with metastatic breast carcinoma in the bone marrow.
    Pruneri G; Cinieri S; Peccatori F; Viale G
    J Clin Oncol; 2005 Jan; 23(1):232-3. PubMed ID: 15625377
    [No Abstract]   [Full Text] [Related]  

  • 15. Discrepancies between the percentage of plasma cells in bone marrow aspiration and BM biopsy: Impact on the revised IMWG diagnostic criteria of multiple myeloma.
    Lee N; Moon SY; Lee JH; Park HK; Kong SY; Bang SM; Lee JH; Yoon SS; Lee DS
    Blood Cancer J; 2017 Feb; 7(2):e530. PubMed ID: 28211888
    [No Abstract]   [Full Text] [Related]  

  • 16. Presence of a bone marrow stromal cell line with myoid differentiation in reactive plasmacytosis and plasma cell myeloma.
    Papadopoulos N; Kotini A; Skaphida P; Jivannakis T; Cheva A; Tamiolakis D
    Acta Haematol; 2003; 109(4):189-92. PubMed ID: 12853691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of bioptic bone marrow imprint in diagnosis of anemia].
    Zhang H; Hu B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Apr; 10(2):131-2. PubMed ID: 12513815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies.
    Chilosi M; Adami F; Lestani M; Montagna L; Cimarosto L; Semenzato G; Pizzolo G; Menestrina F
    Mod Pathol; 1999 Dec; 12(12):1101-6. PubMed ID: 10619261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement.
    Billadeau D; Prosper F; Verfaillie C; Weisdorf D; Van Ness B
    Leukemia; 1997 Sep; 11(9):1565-70. PubMed ID: 9305613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.
    Bouchnita A; Eymard N; Moyo TK; Koury MJ; Volpert V
    Am J Hematol; 2016 Jun; 91(4):371-8. PubMed ID: 26749142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.